References
- Alzheimer's Disease International (2004): Annual Report 2003/2004, Alzheimer's Disease International, London.
- Elgorashi EE, Stafford GI, van Staden J (2004): Acetycholinesterase enzyme inhibitory effects of Amaryllidaceae alkaloids. Planta Med 79: 258–260. [CSA]
- Gijbels MJM, Fischer FC, Scheffer JJC, Baerheim Svendsen A (1984): Phthalides in roots of Capnophyllum peregrinum. and Peucedanum ostruthium.. Planta Med 150: 110. [CSA]
- Grossberg GT (2003): Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on. Curr Ther Res 64: 216–235. [CSA], [CROSSREF]
- Hiermann A, Schantl D (1998): Antiphlogistic and antipyretic activity of Peucedanum ostruthium.. Planta Med 64: 400–403. [PUBMED], [INFOTRIEVE], [CSA]
- Hörhammer L, Wagner H, Heydweiller D (1969): Hesperidin aus dem Rhizom von Peucedanum ostruthium.. Phytochemistry 8: 1605–1606. [CSA], [CROSSREF]
- Kang SY, Lee KY, Sung SH, Park MJ, Kim YC (2001): Coumarins isolated from Angelica gigas. inhibit acetylcholinesterase: Structure-activity relationships. J. Nat Prod 64: 683–685. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Khaled SA, Szendrei K, Novák I, Reisch J (1975): Coumarin glycosides from Peucedanum ostruthium.. Phytochemistry 14: 1461–1462. [CSA], [CROSSREF]
- Marston A, Kissling J, Hostettmann K (2002): A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants. Phytochem Anal 13: 51–54. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scarpini E, Scheltens P, Feldman H (2003): Treatment of Alzheimer's disease: Current status and new perspectives. Lancet Neurol 2: 539–547. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schinkovitz A, Gibbons S, Stavri M, Cocksedge MJ, Bucar F (2003): Ostruthin: An antimycobacterial coumarin from the roots of Peucedanum ostruthium.. Planta Med 69: 369–371. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Urbain A, Marston A, Queiroz EF, Ndjoko K, Hostettmann K (2004): Xanthones from Gentiana campestris. as new acetylcholinesterase inhibitors. Planta Med 70: 1101–1014. [CSA], [CROSSREF]
- Zangara A (2003): The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav 75: 675–686. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]